HEADER SIGNALING PROTEIN 25-MAR-11 2YEM TITLE CRYSTAL STRUCTURE OF THE SECOND BROMODOMAIN OF HUMAN BRD4 WITH THE TITLE 2 INHIBITOR GW841819X COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 4; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: C-TERMINAL BROMODOMAIN, RESIDUES 333-460; COMPND 5 SYNONYM: PROTEIN HUNK1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SIGNALING PROTEIN, HISTONE, EPIGENETIC READER EXPDTA X-RAY DIFFRACTION AUTHOR C.W.CHUNG REVDAT 4 20-DEC-23 2YEM 1 REMARK REVDAT 3 21-AUG-19 2YEM 1 REMARK REVDAT 2 08-MAY-13 2YEM 1 COMPND REVDAT 1 15-JUN-11 2YEM 0 JRNL AUTH C.W.CHUNG,H.COSTE,J.H.WHITE,O.MIRGUET,J.WILDE,R.L.GOSMINI, JRNL AUTH 2 C.DELVES,S.M.MAGNY,R.WOODWARD,S.A.HUGHES,E.V.BOURSIER, JRNL AUTH 3 H.FLYNN,A.M.BOUILLOT,P.BAMBOROUGH,J.M.BRUSQ,F.J.GELLIBERT, JRNL AUTH 4 E.J.JONES,A.M.RIOU,P.HOMES,S.L.MARTIN,I.J.UINGS,J.TOUM, JRNL AUTH 5 C.A.CLEMENT,A.B.BOULLAY,R.L.GRIMLEY,F.M.BLANDEL,R.K.PRINJHA, JRNL AUTH 6 K.LEE,J.KIRILOVSKY,E.NICODEME JRNL TITL DISCOVERY AND CHARACTERIZATION OF SMALL MOLECULE INHIBITORS JRNL TITL 2 OF THE BET FAMILY BROMODOMAINS. JRNL REF J.MED.CHEM. V. 54 3827 2011 JRNL REFN ISSN 0022-2623 JRNL PMID 21568322 JRNL DOI 10.1021/JM200108T REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 52.27 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 14004 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 745 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 998 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.05 REMARK 3 BIN R VALUE (WORKING SET) : 0.2480 REMARK 3 BIN FREE R VALUE SET COUNT : 60 REMARK 3 BIN FREE R VALUE : 0.2690 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1802 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 133 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 36.96 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.49 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.13000 REMARK 3 B22 (A**2) : -0.90000 REMARK 3 B33 (A**2) : -2.23000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.250 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.205 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.142 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.062 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.930 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1966 ; 0.008 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 1386 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2652 ; 1.081 ; 1.975 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3363 ; 0.820 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 231 ; 4.524 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 90 ;31.148 ;23.667 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 354 ;15.899 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 11 ;18.170 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 261 ; 0.057 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2269 ; 0.003 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 452 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1136 ; 0.721 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 443 ; 0.090 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1833 ; 1.435 ; 4.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 830 ; 1.792 ; 4.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 816 ; 2.756 ; 6.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 349 A 458 REMARK 3 ORIGIN FOR THE GROUP (A): -4.7633 6.4512 -24.0448 REMARK 3 T TENSOR REMARK 3 T11: 0.0138 T22: 0.0439 REMARK 3 T33: 0.0833 T12: -0.0109 REMARK 3 T13: 0.0005 T23: 0.0084 REMARK 3 L TENSOR REMARK 3 L11: 0.7726 L22: 3.5029 REMARK 3 L33: 3.1457 L12: -0.1314 REMARK 3 L13: 0.2766 L23: 0.0924 REMARK 3 S TENSOR REMARK 3 S11: -0.0615 S12: -0.0586 S13: 0.0249 REMARK 3 S21: 0.0114 S22: 0.0895 S23: -0.0672 REMARK 3 S31: -0.1683 S32: 0.1675 S33: -0.0280 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 349 B 459 REMARK 3 ORIGIN FOR THE GROUP (A): -1.9962 3.6294 -45.0215 REMARK 3 T TENSOR REMARK 3 T11: 0.0320 T22: 0.1269 REMARK 3 T33: 0.0375 T12: -0.0376 REMARK 3 T13: 0.0259 T23: -0.0238 REMARK 3 L TENSOR REMARK 3 L11: 3.6045 L22: 2.8329 REMARK 3 L33: 4.9280 L12: -1.2955 REMARK 3 L13: 2.4160 L23: -1.5470 REMARK 3 S TENSOR REMARK 3 S11: -0.1143 S12: 0.2679 S13: 0.0460 REMARK 3 S21: -0.1892 S22: 0.0090 S23: -0.2127 REMARK 3 S31: -0.0754 S32: 0.6317 S33: 0.1053 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2YEM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-MAR-11. REMARK 100 THE DEPOSITION ID IS D_1290047844. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-SEP-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9765 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14749 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 73.490 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : 4.30 REMARK 200 R MERGE FOR SHELL (I) : 0.46000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1OUO REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.5 M (NH4)2SO4, 0.1 M TRIS PH 8.5. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.83700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.18100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.74600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.18100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.83700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.74600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 331 REMARK 465 MET A 332 REMARK 465 LYS A 333 REMARK 465 ASP A 334 REMARK 465 VAL A 335 REMARK 465 PRO A 336 REMARK 465 ASP A 337 REMARK 465 SER A 338 REMARK 465 GLN A 339 REMARK 465 GLN A 340 REMARK 465 HIS A 341 REMARK 465 PRO A 342 REMARK 465 ALA A 343 REMARK 465 PRO A 344 REMARK 465 GLU A 345 REMARK 465 LYS A 346 REMARK 465 SER A 347 REMARK 465 SER A 348 REMARK 465 ASP A 459 REMARK 465 GLU A 460 REMARK 465 SER B 331 REMARK 465 MET B 332 REMARK 465 LYS B 333 REMARK 465 ASP B 334 REMARK 465 VAL B 335 REMARK 465 PRO B 336 REMARK 465 ASP B 337 REMARK 465 SER B 338 REMARK 465 GLN B 339 REMARK 465 GLN B 340 REMARK 465 HIS B 341 REMARK 465 PRO B 342 REMARK 465 ALA B 343 REMARK 465 PRO B 344 REMARK 465 GLU B 345 REMARK 465 LYS B 346 REMARK 465 SER B 347 REMARK 465 SER B 348 REMARK 465 GLU B 460 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE WSH A 1459 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE WSH B 1460 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2YEL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 WITH THE REMARK 900 INHIBITOR GW841819X REMARK 900 RELATED ID: 2YEK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD2 WITH THE REMARK 900 INHIBITOR GSK525762 (IBET) DBREF 2YEM A 333 460 UNP O60885 BRD4_HUMAN 333 460 DBREF 2YEM B 333 460 UNP O60885 BRD4_HUMAN 333 460 SEQADV 2YEM SER A 331 UNP O60885 EXPRESSION TAG SEQADV 2YEM MET A 332 UNP O60885 EXPRESSION TAG SEQADV 2YEM SER B 331 UNP O60885 EXPRESSION TAG SEQADV 2YEM MET B 332 UNP O60885 EXPRESSION TAG SEQRES 1 A 130 SER MET LYS ASP VAL PRO ASP SER GLN GLN HIS PRO ALA SEQRES 2 A 130 PRO GLU LYS SER SER LYS VAL SER GLU GLN LEU LYS CYS SEQRES 3 A 130 CYS SER GLY ILE LEU LYS GLU MET PHE ALA LYS LYS HIS SEQRES 4 A 130 ALA ALA TYR ALA TRP PRO PHE TYR LYS PRO VAL ASP VAL SEQRES 5 A 130 GLU ALA LEU GLY LEU HIS ASP TYR CYS ASP ILE ILE LYS SEQRES 6 A 130 HIS PRO MET ASP MET SER THR ILE LYS SER LYS LEU GLU SEQRES 7 A 130 ALA ARG GLU TYR ARG ASP ALA GLN GLU PHE GLY ALA ASP SEQRES 8 A 130 VAL ARG LEU MET PHE SER ASN CYS TYR LYS TYR ASN PRO SEQRES 9 A 130 PRO ASP HIS GLU VAL VAL ALA MET ALA ARG LYS LEU GLN SEQRES 10 A 130 ASP VAL PHE GLU MET ARG PHE ALA LYS MET PRO ASP GLU SEQRES 1 B 130 SER MET LYS ASP VAL PRO ASP SER GLN GLN HIS PRO ALA SEQRES 2 B 130 PRO GLU LYS SER SER LYS VAL SER GLU GLN LEU LYS CYS SEQRES 3 B 130 CYS SER GLY ILE LEU LYS GLU MET PHE ALA LYS LYS HIS SEQRES 4 B 130 ALA ALA TYR ALA TRP PRO PHE TYR LYS PRO VAL ASP VAL SEQRES 5 B 130 GLU ALA LEU GLY LEU HIS ASP TYR CYS ASP ILE ILE LYS SEQRES 6 B 130 HIS PRO MET ASP MET SER THR ILE LYS SER LYS LEU GLU SEQRES 7 B 130 ALA ARG GLU TYR ARG ASP ALA GLN GLU PHE GLY ALA ASP SEQRES 8 B 130 VAL ARG LEU MET PHE SER ASN CYS TYR LYS TYR ASN PRO SEQRES 9 B 130 PRO ASP HIS GLU VAL VAL ALA MET ALA ARG LYS LEU GLN SEQRES 10 B 130 ASP VAL PHE GLU MET ARG PHE ALA LYS MET PRO ASP GLU HET WSH A1459 32 HET WSH B1460 32 HETNAM WSH BENZYL [(4R)-1-METHYL-6-PHENYL-4H-[1,2,4]TRIAZOLO[4,3- HETNAM 2 WSH A][1,4]BENZODIAZEPIN-4-YL]CARBAMATE FORMUL 3 WSH 2(C25 H21 N5 O2) FORMUL 5 HOH *133(H2 O) HELIX 1 1 LYS A 349 PHE A 365 1 17 HELIX 2 2 ALA A 366 LYS A 368 5 3 HELIX 3 3 HIS A 369 TRP A 374 1 6 HELIX 4 4 PRO A 375 TYR A 377 5 3 HELIX 5 5 ASP A 381 GLY A 386 1 6 HELIX 6 6 ASP A 389 ILE A 394 1 6 HELIX 7 7 ASP A 399 ALA A 409 1 11 HELIX 8 8 ASP A 414 ASN A 433 1 20 HELIX 9 9 HIS A 437 LYS A 456 1 20 HELIX 10 10 LYS B 349 PHE B 365 1 17 HELIX 11 11 ALA B 366 LYS B 368 5 3 HELIX 12 12 HIS B 369 TRP B 374 1 6 HELIX 13 13 PRO B 375 TYR B 377 5 3 HELIX 14 14 ASP B 381 GLY B 386 1 6 HELIX 15 15 ASP B 389 ILE B 394 1 6 HELIX 16 16 ASP B 399 ALA B 409 1 11 HELIX 17 17 ASP B 414 ASN B 433 1 20 HELIX 18 18 HIS B 437 LYS B 456 1 20 SITE 1 AC1 7 PRO A 375 ARG A 413 ASN A 433 VAL A 439 SITE 2 AC1 7 HOH A2034 HOH A2067 WSH B1460 SITE 1 AC2 10 TRP A 374 WSH A1459 TRP B 374 PRO B 375 SITE 2 AC2 10 LEU B 387 ASN B 433 HIS B 437 GLU B 438 SITE 3 AC2 10 VAL B 439 HOH B2021 CRYST1 59.674 73.492 74.362 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016758 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013607 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013448 0.00000